Katja Gustafsson

Katja Gustafsson has a strong background in regulatory affairs, with extensive experience in the field. Katja is currently serving as the Vice President of Regulatory Affairs at Hansa Biopharma AB (publ), a position they have held since March 2020. Prior to this, they worked as a Senior Consultant at NDA Regulatory Service from November 2018 to March 2020.

From 2010 to 2018, Katja worked at Ferring Pharmaceuticals A/S, initially as an Associate Director in Urology, Lifecycle Management, and Global Regulatory Affairs. Katja then transitioned into the role of Associate Director in Urology and Global Regulatory Affairs from February 2008 to January 2010, followed by serving as a Senior Regulatory Manager from June 2001 to February 2008. Katja'scareer at Ferring Pharmaceuticals started in January 2000 when they joined as a Global Regulatory Affairs Manager.

Prior to joining Ferring Pharmaceuticals, Katja worked as a Registration Officer at Alpharma ApS from 1996 to 2000.

Katja Gustafsson pursued their education at the Royal Danish School of Pharmacy from 1990 to 1995, where they earned a Master of Science (M.Sc.) degree in Pharmacology. Concurrently, from 1990 to 1996, they also attended another institution to obtain a Master of Science (MSc) degree in Pharmacy.